Cullinan Associates Inc. decreased its position in shares of Exelon Co. (NASDAQ:EXC – Free Report) by 10.0% in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 7,187 shares of the company’s stock after selling 800 shares during the quarter. Cullinan Associates Inc.’s holdings in Exelon were worth $270,000 as of its most recent SEC filing.
Other institutional investors and hedge funds have also recently modified their holdings of the company. Diversified Trust Co raised its position in Exelon by 105.5% during the first quarter. Diversified Trust Co now owns 34,091 shares of the company’s stock valued at $1,281,000 after acquiring an additional 17,503 shares in the last quarter. AMF Tjanstepension AB raised its position in Exelon by 61.5% during the first quarter. AMF Tjanstepension AB now owns 2,012,282 shares of the company’s stock valued at $75,626,000 after acquiring an additional 766,558 shares in the last quarter. Register Financial Advisors LLC purchased a new position in Exelon during the first quarter valued at approximately $26,000. Wealth Enhancement Advisory Services LLC raised its position in Exelon by 49.6% during the first quarter. Wealth Enhancement Advisory Services LLC now owns 110,227 shares of the company’s stock valued at $4,141,000 after acquiring an additional 36,548 shares in the last quarter. Finally, Viking Fund Management LLC raised its position in Exelon by 72.9% during the first quarter. Viking Fund Management LLC now owns 60,500 shares of the company’s stock valued at $2,273,000 after acquiring an additional 25,500 shares in the last quarter. Institutional investors and hedge funds own 80.92% of the company’s stock.
Exelon Stock Down 0.1 %
Shares of EXC opened at $34.53 on Wednesday. The company has a debt-to-equity ratio of 1.64, a quick ratio of 0.93 and a current ratio of 1.03. Exelon Co. has a one year low of $33.35 and a one year high of $43.53. The stock has a market capitalization of $34.53 billion, a price-to-earnings ratio of 14.88, a PEG ratio of 2.52 and a beta of 0.52. The stock has a 50 day moving average price of $36.71 and a 200 day moving average price of $36.22.
Exelon Dividend Announcement
The business also recently announced a quarterly dividend, which was paid on Friday, June 14th. Shareholders of record on Monday, May 13th were issued a $0.38 dividend. This represents a $1.52 annualized dividend and a yield of 4.40%. The ex-dividend date was Friday, May 10th. Exelon’s payout ratio is currently 65.52%.
Analyst Ratings Changes
Several research analysts recently weighed in on EXC shares. StockNews.com upgraded Exelon from a “sell” rating to a “hold” rating in a research report on Monday, March 25th. Barclays upped their target price on Exelon from $36.00 to $39.00 and gave the stock an “overweight” rating in a research note on Thursday, March 14th. Morgan Stanley dropped their price target on shares of Exelon from $41.00 to $39.00 and set an “equal weight” rating on the stock in a research note on Monday, June 24th. Scotiabank reduced their price objective on shares of Exelon from $39.00 to $37.00 and set a “sector perform” rating for the company in a research report on Monday, April 22nd. Finally, Wells Fargo & Company increased their price objective on shares of Exelon from $39.00 to $40.00 and gave the company an “equal weight” rating in a report on Friday, May 3rd. Eleven investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus target price of $38.91.
Read Our Latest Analysis on EXC
About Exelon
Exelon Corporation, a utility services holding company, engages in the energy distribution and transmission businesses in the United States and Canada. The company is involved in the purchase and regulated retail sale of electricity and natural gas, transmission and distribution of electricity, and distribution of natural gas to retail customers.
Featured Stories
- Five stocks we like better than Exelon
- What is a Special Dividend?
- RXO Shares Surge Following New Acquisition Deal
- Technology Stocks Explained: Here’s What to Know About Tech
- 3 Stock Dips Insiders Are Buying: Vestis, Shenandoah, Treace
- What Investors Need to Know About Upcoming IPOs
- Biotech Stock Breakout: IBB Eyes Resistance with Amgen and Vertex
Receive News & Ratings for Exelon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exelon and related companies with MarketBeat.com's FREE daily email newsletter.